A little profit-taking in biotech into year end is only to be expected from Wall Street after such a strong year. Some of the most likely victims for a bit of bloodletting are the strongest winners. Or these companies….[Read More]
Best and worst 2014 biotech performers on Wall Street
by admin | Dec 23, 2014 | biotech, supply chain management | 0 comments